{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T01:25:47Z","timestamp":1771982747773,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:00:00Z","timestamp":1749945600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology Case Reports"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.eucr.2025.103105","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T11:52:14Z","timestamp":1750074734000},"page":"103105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Fibroblast-directed PET imaging reveals a case of retroperitoneal fibrosis after immunotherapy for metastatic urothelial cancer of the upper tract"],"prefix":"10.1016","volume":"61","author":[{"given":"L.","family":"Gallardo Zamora","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.C.","family":"von Rundstedt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Wach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.P.","family":"Fendler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Maric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.T.","family":"Siveke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.F.-Y.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Gr\u00fcnwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.eucr.2025.103105_bib1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.eururo.2023.03.013","article-title":"European association of urology guidelines on upper urinary tract urothelial carcinoma: 2023 update","volume":"84","author":"Roupr\u00eat","year":"2023","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.eucr.2025.103105_bib2","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.eururo.2020.07.003","article-title":"Neoadjuvant and adjuvant chemotherapy for upper tract urothelial carcinoma: a 2020 systematic review and meta-analysis, and future perspectives on systemic therapy","volume":"79","author":"Leow","year":"2021","journal-title":"Eur Urol"},{"issue":"23","key":"10.1016\/j.eucr.2025.103105_bib3","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1200\/JCO.19.01213","article-title":"Long-term outcomes in KEYNOTE-052: phase II study investigating first-line pembrolizumab in cisplatin-ineligible patients with locally advanced or metastatic urothelial cancer","volume":"38","author":"Vuky","year":"2020","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.eucr.2025.103105_bib4","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S1470-2045(21)00152-2","article-title":"Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial","volume":"22","author":"Powles","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eucr.2025.103105_bib5","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3389\/fphar.2017.00730","article-title":"Immune-related adverse events associated with Anti-PD-1\/PD-L1 treatment for malignancies: a meta-analysis","volume":"8","author":"Wang","year":"2017","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.eucr.2025.103105_bib6","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jbspin.2017.05.024","article-title":"Retroperitoneal fibrosis following a long-standing etanercept treatment in a spondyloarthritis patient","volume":"85","author":"Manganelli","year":"2018","journal-title":"Jt Bone Spine"},{"issue":"9","key":"10.1016\/j.eucr.2025.103105_bib7","doi-asserted-by":"crossref","first-page":"e329","DOI":"10.1093\/rheumatology\/keab264","article-title":"Anti-PD-1 associated retroperitoneal fibrosis","volume":"60","author":"Daoussis","year":"2021","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.eucr.2025.103105_bib8","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1007\/s00259-019-04352-1","article-title":"Retroperitoneal fibrosis in on-going anti-PD-1 immunotherapy detected with [18F]-FDG PET\/CT","volume":"46","author":"Moreau","year":"2019","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"7","key":"10.1016\/j.eucr.2025.103105_bib10","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00120-017-0428-y","article-title":"Neue (und alte) Aspekte der retroperitonealen Fibrose","volume":"56","author":"Brandt","year":"2017","journal-title":"Urologe"},{"issue":"4","key":"10.1016\/j.eucr.2025.103105_bib11","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s11307-022-01715-3","article-title":"Head-to-head intra-individual comparison of [68Ga]-FAPI and [18F]-FDG PET\/CT in patients with bladder cancer","volume":"24","author":"Novruzov","year":"2022","journal-title":"Mol Imag Biol"},{"issue":"1","key":"10.1016\/j.eucr.2025.103105_bib12","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/1759-7714.15155","article-title":"IgG4-related retroperitoneal fibrosis induced by nivolumab and ipilimumab in a patient with non-small cell lung cancer: a case report","volume":"15","author":"Nishimura","year":"2024","journal-title":"Thorac Cancer"},{"issue":"10232","key":"10.1016\/j.eucr.2025.103105_bib13","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0140-6736(20)30415-3","article-title":"Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial","volume":"395","author":"Birtle","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.eucr.2025.103105_bib14","article-title":"Malignant retroperitoneal fibrosis in lung adenocarcinoma","volume":"4","author":"Uy","year":"2021","journal-title":"Curr Probl Cancer: Case Reports"},{"issue":"3","key":"10.1016\/j.eucr.2025.103105_bib15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cpet.2021.03.012","article-title":"The role of fibroblast activation protein ligands in oncologic PET imaging","volume":"16","author":"Dendl","year":"2021","journal-title":"Pet Clin"},{"issue":"6","key":"10.1016\/j.eucr.2025.103105_bib16","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2967\/jnumed.119.227967","article-title":"68Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer","volume":"60","author":"Kratochwil","year":"2019","journal-title":"J Nucl Med"}],"container-title":["Urology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214442025001767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214442025001767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T14:21:17Z","timestamp":1762611677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214442025001767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":15,"alternative-id":["S2214442025001767"],"URL":"https:\/\/doi.org\/10.1016\/j.eucr.2025.103105","relation":{},"ISSN":["2214-4420"],"issn-type":[{"value":"2214-4420","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibroblast-directed PET imaging reveals a case of retroperitoneal fibrosis after immunotherapy for metastatic urothelial cancer of the upper tract","name":"articletitle","label":"Article Title"},{"value":"Urology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eucr.2025.103105","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103105"}}